Perspective Therapeutics (CATX) Total Non-Current Liabilities (2011 - 2026)

Perspective Therapeutics has reported Total Non-Current Liabilities for 16 years, with the latest figure at $62.9 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 41.15% year-over-year to $62.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $62.9 million (up 41.15% YoY) and the FY2025 annual result came in at $59.6 million, up 18.22% from the prior year.
• Total Non-Current Liabilities advanced to $62.9 million in Q1 2026 per CATX's latest filing, from $59.6 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $62.9 million in Q1 2026 and troughed at $2.3 million in Q1 2022.
• A 5-year average of $30.5 million and a median of $33.6 million in 2023 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities jumped 713.47% in 2023, then fell 16.57% in 2025.
• Over 5 years, Total Non-Current Liabilities stood at $2.8 million in 2022, then surged by 713.47% to $22.7 million in 2023, then jumped by 121.81% to $50.4 million in 2024, then gained by 18.22% to $59.6 million in 2025, then increased by 5.61% to $62.9 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $62.9 million, $59.6 million, and $52.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.